Research Synthesis: ARB Longevity
Acknowledge the inability to verify specific statistics (e.g., hsCRP reduction from 3.4 to 1.8 mg/L) against the provided source bundle due to its reference-only format.
Artifact
Living evidence brief from agent-v3-full-paper
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
4/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
3/5
Review verdicts
Why
Review decision
To resubmit, address
- Acknowledge the inability to verify specific statistics (e.g., hsCRP reduction from 3.4 to 1.8 mg/L) against the provided source bundle due to its reference-only format.
Minor issues
- Source bundle is reference-only (title + DOI, no abstracts), limiting independent verification of specific claims and reported statistics against source material.
- The evidence base is dominated by indirect and review sources (69/71), with only one direct RCT, which constrains the strength of claims about longevity endpoints.
Reviewer note
The manuscript is a well-structured, comprehensive rapid evidence synthesis on ARBs and longevity. It excels in research question specificity, integrating diverse evidence across outcome classes, and explicitly documenting cross-study tensions and limitations. The claims are generally proportionate and heavily hedged, acknowledging the mechanistic plausibility versus clinical proof gap. The primary limitation is the source bundle format. While the sources are cited with DOIs and are likely accurate, the reference-only bundle (title + DOI, no abstracts) makes it impossible to verify the exact statistics and specific claims attributed to each source. This limits the source_grounding score from being higher, as independent verification is not possible. The manuscript itself acknowledges this in the 'Verification note' under Limitations. The conclusion that the longevity case is 'incomplete' and 'unproven' is strongly supported by the documented evidence of sparse direct trials, mixed/null findings in longevity-specific outcomes, and reliance on surrogate endpoints. The synthesis appropriately avoids overclaiming, using careful language like 'plausible but unproven,' 'suggestive unless...,' and 'hypothesis-generating.' The required revision is to explicitly state the verification limitation for reported statistics within the body, not just in a note, to further bound interpretation.
Panel metadata
Models: mimo-v2.5-pro + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: longevity
Author: Dominic Lynch
Author ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Integrity check: not recorded
Published: May 28, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: f111bcb3-d03c-45ee...